| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/24/2003 | US20030138779 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 07/24/2003 | US20030138777 Autonomous prototrophic/auxotrophic genetic system coding minimal gene set comprised of transcription, translation, aerobic metabolism, glycolysis/pyruvate dehydrogenase/pentose phosphate and nucleotide metabolism pathways |
| 07/24/2003 | US20030138773 Methods of transcriptionally modulating gene expression |
| 07/24/2003 | US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy |
| 07/24/2003 | US20030138770 Detection and characterization of microorganisms |
| 07/24/2003 | US20030138769 Immunogenic HBc chimer particles having enhanced stability |
| 07/24/2003 | US20030138461 Process for the in vitro culture of different stages of tissular parasites |
| 07/24/2003 | US20030138458 HCV E1E2 vaccine compositions |
| 07/24/2003 | US20030138457 Such as F protein of Paramyxovirus SV5 strain; this recombinant Rhabdovirus may express other non-Rhabdovirus attachment proteins and/or an enhancer protein; for diagnostic and therapeutic compositions for treatment of diseases |
| 07/24/2003 | US20030138456 Vaccines expressed in plants |
| 07/24/2003 | US20030138454 Vaccination method |
| 07/24/2003 | US20030138453 Microparticles comprise a polymer such as a poly(alpha-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, a polyorthoester, a polyanhydride, formed using cationic, anionic, or nomonic detergents; drug delivery |
| 07/24/2003 | US20030138447 Derivatives of choline binding proteins for vaccines |
| 07/24/2003 | US20030138446 Nucleic acid vaccine to protect salmon against piscirickettsiosis salmonis a gramnegative bacteria |
| 07/24/2003 | US20030138445 gp41 antigen |
| 07/24/2003 | US20030138444 Composition and method for treating HIV infection |
| 07/24/2003 | US20030138442 Protein- or polynucleic acid-based vaccine which protects a pig against porcine reporductive and respiratory syndrome |
| 07/24/2003 | US20030138441 A polynucleotide sequence which encodes a Dermatophagoides dust mite protein, wherein the codon usage pattern of the polynucleotide sequence resembles that of highly expressed mammalian genes |
| 07/24/2003 | US20030138440 Multimeric proteins and methods of making and using same |
| 07/24/2003 | US20030138429 Compositions and methods for inhibiting metastasis |
| 07/24/2003 | US20030138424 An antibody capable of inhibiting the binding between parathyroid hormone related protein (PTHrP) and a receptor; antagonists; systemic disorders caused by cancer; anorexic agents; anemia, electrolyte imbalance; immunotherapy |
| 07/24/2003 | US20030138422 Antibodies against growth and differentiation factor-8 (GDF-8), also known as myostatin, including fragments; muscle and bone degenerative disorders; muscular dystropy/atrophy; antidiabetic agents; congestive obstructive pulmonary disease |
| 07/24/2003 | US20030138421 Human Antibodies specific for interleukin 15 (IL-15) |
| 07/24/2003 | US20030138411 Gene expression in monocytes and macrophages |
| 07/24/2003 | US20030138410 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 07/24/2003 | US20030138405 An adenovirus encoding an E1A polypeptide unable to bind the tumor suppressor protein retinoblastomas (Rb) may replicate in or kill a cell having a defective Rb pathway but not the non-mutant cells; gliomas; gene therapy; antitumor agents |
| 07/24/2003 | US20030138363 Device for chemical and biochemical reactions using photo-generated reagents |
| 07/24/2003 | US20030138208 Grating optical waveguide structure for multi-analyte determinations and the use thereof |
| 07/24/2003 | US20030136918 Soft ionization device and applications thereof |
| 07/24/2003 | CA2841097A1 Albumin fusion proteins |
| 07/24/2003 | CA2765340A1 Novel calpastatin (cast) alleles |
| 07/24/2003 | CA2680946A1 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 07/24/2003 | CA2484556A1 Albumin fusion proteins |
| 07/24/2003 | CA2477348A1 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 07/24/2003 | CA2475993A1 Defective entities and uses therefor |
| 07/24/2003 | CA2474151A1 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/24/2003 | CA2474138A1 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system |
| 07/24/2003 | CA2474044A1 Compositions and methods for identifying transformed cells |
| 07/24/2003 | CA2474002A1 Bispecific antibody dna constructs for intramuscular administration |
| 07/24/2003 | CA2473909A1 Cloning b and t lymphocytes |
| 07/24/2003 | CA2473613A1 Method for the quantification of in vivo nucleic acid levels |
| 07/24/2003 | CA2473570A1 Antisense compounds directed against human csf-1 |
| 07/24/2003 | CA2473434A1 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 07/24/2003 | CA2473229A1 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | CA2473082A1 Verification of fish origin based on nucleic acid pattern recognition |
| 07/24/2003 | CA2473039A1 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | CA2472759A1 Gb virus b based replicons and replicon enhanced cells |
| 07/24/2003 | CA2472498A1 Petal-array support for use with microplates |
| 07/24/2003 | CA2472468A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 07/24/2003 | CA2472462A1 Efficient nucleic acid encapsulation into medium sized liposomes |
| 07/24/2003 | CA2472452A1 Rabbit nuclear cloning method and uses thereof |
| 07/24/2003 | CA2472423A1 Process for producing kiss-1 peptide |
| 07/24/2003 | CA2472381A1 Glycosyltransferase gnt-v having neovascularization action |
| 07/24/2003 | CA2472072A1 Means for identifying neisseiria menengitidis specific genes |
| 07/24/2003 | CA2472016A1 Method and device for identifying substances capable of modulating adipicyte differentiation |
| 07/24/2003 | CA2471891A1 Methods of inducing or enhancing connective tissue repair |
| 07/24/2003 | CA2471744A1 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | CA2471702A1 Human monoclonal antibodies against cd30 |
| 07/24/2003 | CA2471513A1 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/24/2003 | CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | CA2471473A1 High fidelity dna polymerase compositions and uses therefor |
| 07/24/2003 | CA2471363A1 Albumin fusion proteins |
| 07/24/2003 | CA2471218A1 Heteroconfigurational polynucleotide and methods of use |
| 07/24/2003 | CA2470527A1 Methods and compositions for generating a genetically modified animal using lentiviral vectors |
| 07/24/2003 | CA2470421A1 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | CA2470400A1 Cultured and encapsulated pancreatic stem cells |
| 07/24/2003 | CA2470359A1 Assay for the detection of factors that modulate the expression of ingap |
| 07/24/2003 | CA2470061A1 Plant cyclopropane fatty acid synthase genes, proteins and uses thereof |
| 07/24/2003 | CA2469715A1 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 07/24/2003 | CA2465178A1 Adapter-directed display system |
| 07/24/2003 | CA2464131A1 Compositions and methods for controlled release |
| 07/24/2003 | CA2463008A1 Efficient protein expression system |
| 07/24/2003 | CA2451443A1 Hyaluronan synthase genes and expression thereof |
| 07/24/2003 | CA2438106A1 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/23/2003 | EP1329523A1 Method of detecting norwalk-like virus (gii) |
| 07/23/2003 | EP1329522A1 Method of detecting norwalk-like virus (gi) |
| 07/23/2003 | EP1329521A1 Method for the detection of ochratoxin A- or citrinin-producing fungi |
| 07/23/2003 | EP1329520A2 Probe for diagnosing infectious disease arising from Staphylococcus aureus |
| 07/23/2003 | EP1329519A2 Probe for diagnosing infectious disease arising from Staphylococcus aureus |
| 07/23/2003 | EP1329518A2 Probe for diagnosing infectious disease arising from Staphylococcus aureus |
| 07/23/2003 | EP1329511A1 Polypeptide having phospholipase a2 actiivty |
| 07/23/2003 | EP1329510A2 Staphylococcus FabD |
| 07/23/2003 | EP1329509A2 Method for generating a subtracted cDNA library and uses of the generated library |
| 07/23/2003 | EP1329508A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/23/2003 | EP1329507A1 Artificial protein having potentiated immunogenicity of epitope |
| 07/23/2003 | EP1329506A1 Method to quantify in vivo RNA levels |
| 07/23/2003 | EP1329504A1 Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like |
| 07/23/2003 | EP1329502A2 Method and apparatus for treating materials with electrical fields having varying orientations |
| 07/23/2003 | EP1329501A1 Novel pla1 |
| 07/23/2003 | EP1329459A2 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 07/23/2003 | EP1329223A1 Expression potentiator for protein synthesis regulatory gene |
| 07/23/2003 | EP1329153A1 Plant having improved tolerance to various environmental stresses, method of constructing the same and polyamine metabolism-relating enzyme gene |
| 07/23/2003 | EP1328880A1 Interactive correlation of compound information and genomic information |
| 07/23/2003 | EP1328816A2 Regulation of neutral development by daedalos |
| 07/23/2003 | EP1328814A2 Method for in vivo identification of intracellular epitopes |
| 07/23/2003 | EP1328810A2 Three dimensional biochip |
| 07/23/2003 | EP1328807A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/23/2003 | EP1328663A2 Assays for identifying receptors having alterations in signaling |
| 07/23/2003 | EP1328661A2 Estrogen receptor alpha variants and methods of detection thereof |
| 07/23/2003 | EP1328656A1 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |